Please use this identifier to cite or link to this item: http://elar.urfu.ru/handle/10995/111569
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChumarnaya, T. V.en
dc.contributor.authorLyubimtseva, T. A.en
dc.contributor.authorSolodushkin, S. I.en
dc.contributor.authorLebedeva, V. K.en
dc.contributor.authorLebedev, D. S.en
dc.contributor.authorSolovieva, O. E.en
dc.date.accessioned2022-05-12T08:19:15Z-
dc.date.available2022-05-12T08:19:15Z-
dc.date.issued2021-
dc.identifier.citationEvaluation of the Long-term Effectiveness of Cardiac Resynchronization Therapy / T. V. Chumarnaya, T. A. Lyubimtseva, S. I. Solodushkin et al. // Russian Journal of Cardiology. — 2021. — Vol. 26. — Iss. 7. — P. 48-60. — 4531.en
dc.identifier.issn1560-4071-
dc.identifier.otherAll Open Access, Gold3
dc.identifier.urihttp://elar.urfu.ru/handle/10995/111569-
dc.description.abstractAim. To determine quantitative criteria for assessing the therapeutic benefits and the most informative time frames after cardiac resynchronization therapy (CRT) to assess its long-term effectiveness (1, 2, 3 years of follow-up) based on retrospective analysis. To assess the CRT effectiveness, parameters of left ventricular (LV) reverse remodeling and signs characterizing the clinical CRT response were considered. Material and methods. This single-center, retrospective, non-randomized study included data from 278 patients with implanted CRT devices. Quantitative criteria for assessing CRT effectiveness were determined using a two-step cluster analysis of patients 1, 2, and 3 years after CRT by LV reverse remodeling parameters. Results. In the dataset with satisfactory division accuracy, after the first year, two clusters were identified, which are conventionally named as “non-responders” and “responders”. Two and three years after therapy, patients were classified into three clusters: “non-responders”, “responders” and “super-responders”. For the obtained clusters, we found cutoff values for LV reverse remodeling parameters, which can be used as criteria for response to therapy. The study identified the most informative time frames for assessing the postoperative CRT effectiveness 1, 2, 3 years after the surgery. At the same time, the clinical response to therapy is manifested earlier in comparison with the reverse LV remodeling. Despite the high divisibility of patients into responders and non-responders, predictive models of CRT effectiveness created using the available data from standard diagnostic protocols for heart failure patients have insufficient accuracy to be used for making decisions on therapy appropriateness. This circumstance indicates the need to receive additional data to improve the forecasting quality. Conclusion. The study revealed a period for assessing the clinical response and changes in LV reverse remodeling after CRT surgery, which is important for the optimal choice of postoperative therapy. It has been shown that in most cases, one year after surgery is sufficient to assess the clinical response, and the process of LV reverse remodeling can last up to two years on average. When assessing the CRT effectiveness by reverse remodeling, along with a change in LV end-systolic volume (ESV), it is necessary to take into account LV end-diastolic volume (EDV) changes. The change in LV ejection fraction showed a significantly lower value among the analyzed parameters in assessing the CRT effectiveness. Based on the cluster classification of patients, a dividing rule was established for responders and non-responders in the first and second years after surgery with an accuracy of 97%: a decrease in LV ESV and EDV by 9% or more compared to preoperative values. © 2021, Silicea-Poligraf. All rights reserved.en
dc.description.sponsorshipRelationships and Activities. This work was supported by a Russian Science Foundation grant № 19-14-00134.en
dc.format.mimetypeapplication/pdfen
dc.language.isoruen
dc.publisherSilicea-Poligrafen1
dc.publisherSilicea - Poligraf, LLCen
dc.relationinfo:eu-repo/grantAgreement/RSF//19-14-00134en
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.sourceRuss. J. Cardiol.2
dc.sourceRussian Journal of Cardiologyen
dc.subjectCARDIAC RESYNCHRONIZATION THERAPYen
dc.subjectCARDIAC RESYNCHRONIZATION THERAPY EFFECTIVENESSen
dc.subjectFORECASTING MODELSen
dc.subjectLONG-TERM POSTOPERATIVE PERIODen
dc.subjectADULTen
dc.subjectARTICLEen
dc.subjectCARDIAC RESYNCHRONIZATION THERAPYen
dc.subjectCLUSTER ANALYSISen
dc.subjectCONTROLLED STUDYen
dc.subjectFOLLOW UPen
dc.subjectFORECASTINGen
dc.subjectHEART FAILUREen
dc.subjectHEART LEFT VENTRICLEen
dc.subjectHEART LEFT VENTRICLE EJECTION FRACTIONen
dc.subjectHEART LEFT VENTRICLE ENDSYSTOLIC VOLUMEen
dc.subjectHEART VENTRICLE REMODELINGen
dc.subjectHUMANen
dc.subjectMAJOR CLINICAL STUDYen
dc.subjectPOSTOPERATIVE PERIODen
dc.subjectRETROSPECTIVE STUDYen
dc.subjectTHERAPY EFFECTen
dc.subjectTREATMENT RESPONSEen
dc.titleEvaluation of the Long-term Effectiveness of Cardiac Resynchronization Therapyen
dc.typeArticleen
dc.typeinfo:eu-repo/semantics/articleen
dc.typeinfo:eu-repo/semantics/publishedVersionen
dc.identifier.rsi46398129-
dc.identifier.doi10.15829/1560-4071-2021-4531-
dc.identifier.scopus85117571207-
local.contributor.employeeChumarnaya, T.V., Institute of Immunology and Physiology, Yekaterinburg, Russian Federation, Ural State Medical Uni-versity, Yekaterinburg, Russian Federation; Lyubimtseva, T.A., Almazov National Medical Research Center, St. Petersburg, Russian Federation; Solodushkin, S.I., Ural Federal University, Yekaterinburg, Russian Federation; Lebedeva, V.K., Almazov National Medical Research Center, St. Petersburg, Russian Federation; Lebedev, D.S., Almazov National Medical Research Center, St. Petersburg, Russian Federation; Solovieva, O.E., Institute of Immunology and Physiology, Yekaterinburg, Russian Federation, Ural Federal University, Yekaterinburg, Russian Federationen
local.description.firstpage48-
local.description.lastpage60-
local.issue7-
local.volume26-
local.contributor.departmentInstitute of Immunology and Physiology, Yekaterinburg, Russian Federation; Ural State Medical Uni-versity, Yekaterinburg, Russian Federation; Almazov National Medical Research Center, St. Petersburg, Russian Federation; Ural Federal University, Yekaterinburg, Russian Federationen
local.identifier.pure23015014-
local.description.order4531-
local.identifier.eid2-s2.0-85117571207-
local.fund.rsf19-14-00134-
Appears in Collections:Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC

Files in This Item:
File Description SizeFormat 
2-s2.0-85117571207.pdf813,89 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.